High-Yield Cardiology for USMLE Step 3: ACS, Heart Failure, and Arrhythmias

Every attending has a "cardiology scar" from Step 3 — that one question where you second-guessed yourself on a STEMI door-to-balloon window or blanked on whether to cardiovert. Cardiology is where the gap between "I reviewed the material" and "I actually understand the decision tree" is widest.

Here's what actually gets tested — and what trips people up.

Acute Coronary Syndromes: It's a Triage Exam

Step 3 doesn't care about plaque pathophysiology. It wants to know: can you run the room?

STEMI: The Clock Is Everything

The STEMI algorithm collapses to one question — how fast can you get this patient to a cath lab?

• PCI available within 90 minutes of first medical contact → primary PCI, no debate
• PCI NOT available within 120 minutes → fibrinolytic therapy (alteplase, reteplase) within 30 minutes of arrival
• Absolute contraindications to lytics: prior intracranial hemorrhage, ischemic stroke within 3 months, suspected aortic dissection, active bleeding

Here's the thing nobody tells you: the CCS exam tests whether you give aspirin before you even order the ECG. Aspirin 325 mg + P2Y12 inhibitor go with either reperfusion strategy. DAPT continues for at least 12 months after drug-eluting stent. Miss the aspirin timing and you've lost points before the troponin results populate.

NSTEMI/Unstable Angina: Risk-Stratify, Don't Memorize

Forget the NSTEMI vs. UA distinction. The exam wants you to risk-stratify and act:

• High-risk (positive troponin, dynamic ST changes, hemodynamic instability, ongoing chest pain): early invasive strategy — cath within 24–48 hours
• Low-risk: medical management, anticoagulation, stress test before discharge

Standard ACS stack: aspirin + P2Y12 inhibitor, anticoagulation (UFH, enoxaparin, or fondaparinux), high-intensity statin (atorvastatin 80 mg), beta-blocker within 24 hours, ACE inhibitor if EF <40%.

A surprising pattern: Step 3 asks about beta-blocker contraindications more than indications. Decompensated HF, cardiogenic shock, high-degree AV block — they want you to withhold the drug. Recognizing when to not treat is half the exam.

Heart Failure: The Pharmacology Gauntlet

HFrEF vs. HFpEF — One Has a Drug List, One Doesn't

HFrEF has a beautiful, testable pharmacology cascade. HFpEF... doesn't. The exam loves that asymmetry.

HFrEF mortality-reducing drugs:

Drug Class	Example	Watch Out For
ACE inhibitor	Lisinopril	Cough, hyperkalemia, angioedema
ARB (ACE-intolerant)	Losartan	Hyperkalemia, teratogenic
ARNI	Sacubitril/valsartan	Replaces ACE/ARB — never combine them
Beta-blocker	Metoprolol succinate, carvedilol	Do NOT initiate in decompensated HF
Aldosterone antagonist	Spironolactone	Avoid if K⁺ >5.0 or Cr >2.5
SGLT-2 inhibitor	Dapagliflozin, empagliflozin	Proven mortality benefit in HFrEF

Non-dihydropyridine calcium channel blockers (verapamil, diltiazem) are contraindicated in systolic HF. They depress contractility and will kill your patient. Step 3 loves this as a wrong-answer trap.

HFpEF: No drug conclusively reduces mortality. Diuretics for symptoms, treat the cause (HTN, AF, CAD), and SGLT-2 inhibitors are showing promise. The contrarian take? Most residents over-study HFpEF for Step 3. The exam rarely asks you to manage it in isolation — it shows up as a distractor testing whether you can distinguish it from HFrEF. Nail the HFrEF cascade cold instead.

Acute Decompensated Heart Failure

Crackles to the apices, orthopnea, BNP through the roof:

1. IV furosemide — first move, always
2. IV nitroglycerin — reduces preload and afterload
3. BiPAP if respiratory distress persists despite diuresis
4. Do NOT start a new beta-blocker in this setting — but continue an existing one at a reduced dose

That last point generates more wrong answers than almost anything in cardiology. "Beta-blockers help in HF" — yes, stable HF. Initiating one during decompensation is dangerous.

Arrhythmias: Two Algorithms, Then Everything Else

Atrial Fibrillation

AF boils down to two parallel decisions: control the rate (or rhythm), and decide on anticoagulation. They're independent. Lots of people conflate them under pressure.

Rate vs. rhythm control:

• Rate control (metoprolol, diltiazem) for most chronic AF — this is the default
• Rhythm control (cardioversion ± antiarrhythmic) for new-onset AF, severely symptomatic patients, or when AF is driving heart failure

Anticoagulation (CHA₂DS₂-VASc):

• Score ≥2 in men, ≥3 in women → anticoagulate
• DOACs (apixaban, rivarexaban, dabigatran) beat warfarin for non-valvular AF
• Exception that gets tested constantly: mechanical heart valves → warfarin only, no DOACs, ever

The 48-hour rule: AF onset clearly <48 hours? Cardiovert without prior anticoagulation. Duration >48 hours or unknown? Anticoagulate 3+ weeks first, or TEE to rule out thrombus. CCS cases make this timeline deliberately vague — they're testing whether you ask about onset.

Unstable Tachycardia: Don't Overthink It

Hypotension, altered mental status, chest pain, or acute HF with any tachyarrhythmia = synchronized cardioversion, immediately. Don't try adenosine, don't order labs. The exam is testing whether you'll hesitate.

Bradyarrhythmias

• Symptomatic bradycardia or high-degree AV block: atropine IV first, transcutaneous pacing if that fails
• Complete (3rd degree) heart block: permanent pacemaker — this patient is getting admitted

Valvular Disease: Three Facts That Cover 90% of Questions

Valvular disease on Step 3 is narrower than people think:

1. Severe aortic stenosis with symptoms (syncope, angina, heart failure) → surgical valve replacement or TAVR. Asymptomatic? Watch and wait. The symptom onset is the trigger.
2. Mitral regurgitation: surgery when EF drops below 60% or end-systolic diameter >40 mm — don't wait for symptoms. This catches people because it's the opposite logic of aortic stenosis.
3. Endocarditis prophylaxis: only for highest-risk patients (prosthetic valve, prior IE, unrepaired cyanotic CHD) undergoing dental procedures. It's not recommended for most valvular disease anymore. The exam loves outdated-practice distractors here.

That MR threshold surprises most test-takers. You operate on numbers, not symptoms — the opposite of AS. Step 3 exploits that cognitive dissonance.

FAQ

How many cardiology questions should I expect on Step 3?

Expect roughly 10–15% of your total questions to involve cardiovascular topics across both exam days. On CCS, at least 1–2 cases will likely involve ACS or arrhythmia management.

Should I memorize every antiarrhythmic drug for Step 3?

No — common time sink. Focus on agents you'd actually use: metoprolol and diltiazem for rate control, amiodarone as the go-to antiarrhythmic, and adenosine for stable SVT. Vaughan-Williams classification is Step 1 territory. Spend those hours on ACS and HF algorithms instead.

What's the most common cardiology mistake on CCS cases?

Forgetting time-dependent orders. In a STEMI CCS case, examinees order the ECG and troponin but delay aspirin, or wait for results before initiating heparin. The simulated clock is running — you're scored on when you place orders, not just what you order. Aspirin and anticoagulation go in before your workup is complete.

Do I need to know hemodynamic tracings and Swan-Ganz numbers?

You need the basics: recognize that cardiogenic shock = high PCWP and hypovolemic shock = low PCWP. You don't need to interpret complex waveform tracings. When a question gives you numbers, it's testing clinical-picture-to-hemodynamic-profile matching, not catheter interpretation.

How do SGLT-2 inhibitors fit into the Step 3 heart failure algorithm?

Must-know now. Dapagliflozin and empagliflozin have proven mortality benefit in HFrEF and are guideline-directed medical therapy alongside ACE inhibitors, beta-blockers, and aldosterone antagonists. Expect at least one question where an SGLT-2 inhibitor is the correct addition to an optimized regimen. Key detail: the benefit is independent of diabetes status.

Put It Into Practice

Cardiology rewards pattern recognition under time pressure — exactly what CCS cases test. Build that instinct with repetition.

Step3Sim offers free USMLE Step 3 practice questions for cardiology and all other organ systems — including CCS simulations where the clock runs and order timing matters.